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“If you are not prepared to be wrong, 
you will never come up with anything original.” 
Sir Kenneth Robinson  



















“It is more important to know what sort of person has a disease, 
than to know what sort of disease a person has.” 
Hippocrates of Kos  




POPULAR SCIENCE SUMMARY OF THE THESIS 
Cleft lip and/or cleft palate, a visible birth defect of the face and mouth, is as old as the 
beginnings of humankind. Yet, it remains as one of the greatest unsolved medical mysteries. 
The birth defect stems from oral and facial malformations in the very early stages of the 
developing embryo in the womb, in the first few months after conception. When something 
goes wrong during the early period of oral and facial development, the upper lip, roof of the 
mouth, and teeth become malformed, often with different combinations of defects and 
degrees of severity.  
The cupid’s bow of a cleft upper lip is split up by one or two gaps. In the old days, the 
common name for cleft lip was harelip as the defect resembled a hare’s split upper lip. Cleft 
palate is a gap or hole in the roof of the mouth, which resembles bone destruction in the 
mouth from syphilis, and that misled medical theories and practices. Even though surgical 
repair of cleft lip evolved from 390 B.C.E., cleft palate repair was not attempted until 1816. 
Professor Girolamo Fabrizi d’Acquapendente, better known in the medical world as the 
Father of Embryology, ushered in the dawn of understanding into the origins of cleft lip and 
palate by his work on the developing foetus in “De Formato Fœtu” (c.1600). The striking 
variations in the physical defects of individuals with isolated cleft lip and/or palate stirred a 
bone of contention as to the cause and effect. There are two brigades of thought on this. The 
first brigade contended the disorder was from complex combinations of many gene mutations 
and environmental factors that tipped the balance towards malformations in the developing 
foetus. The other brigade mounted fresh evidence on family inheritance of mutated genes as 
well as new gene mutations causing cleft lip with or without cleft palate that are not inherited 
from either parent. 
The Father of Medicine, Hippocrates of Kos, once said, “It is more important to know what 
sort of person has a disease than to know what sort of disease a person has.” Not all 
individuals with the same mutated genes have similar risks to cleft malformations. There are 
different tallies of babies born with cleft defects from different ancestral backgrounds. 
Pervasiveness of cleft births was similar to their ancestors that did not change with relocation 
to new countries. The gender of babies born with clefts mattered as well. It was more common 
for boys than girls to be born with cleft malformations. Babies born with cleft lip were more 
likely to be males whereas babies with cleft palate were more commonly females. Unusual 
patterns of teeth and slow developing teeth implicated their involvement in the disorder. The 
 
 
unique dental patterns distinguished teeth and their development in individuals with cleft 
malformations. These were possible biological markers or biomarkers to identify differences 
in those with orofacial clefts. In children without cleft malformations, the chances of having 
malformed, missing or slow teeth are small. Teeth form from special cells called neural crest 
cells that are found next to the spinal cord in the developing foetus. These cells migrate to 
the head in many segments that unite to form the face, jaws and teeth. It stands to reason that 
teeth can be affected when the tooth-bearing parts of the jaw fail to form or are improperly 
joined together. Teeth next to the cleft defect in the jaw bone may be malformed, smaller 
than normal, or missing, although there are also reports of teeth located away from the cleft 
defect that are malformed or missing. It is uncertain if the remote dental defects are inherent, 
part of the cleft disorder, or due to disturbed development from the effects of early surgery 
to repair the lip and palate defects.  
To avoid the confusion from a variety of reasons for abnormal dental development, it is 
important to distinguish people of different ancestries, males and females, individuals with 
overlapping cleft-types, or effects from before and after surgery that contribute to the 
disorder. This series of research seeks to establish the frequency and type of dental 
biomarkers in infants and children with orofacial clefts from different ancestries, with and 
without overlapping cleft defects, with and without surgery. We found extra baby incisors on 
the same side of the cleft defect in unoperated infants with cleft lip only. The extra incisor 
was surmised to be a disturbance in tooth formation after the segments of bone in the 
rudimentary upper jaw were fused. No extra nor missing teeth were found in unoperated 
infants with isolated cleft palate, which indicated tooth development was probably separate 
from palate formation. Dental development was slow in all unoperated infants with different 
types of cleft defects, slower in the group with cleft lip than the group with cleft palate. Males 
were slower in tooth development than females. Slow tooth development also occurred in 
operated children with cleft lip and palate between 5 to 9 years of age. As these children grew 
older, tooth formation came up to speed between 9 to 13 years of age and paralleled that of 
children without clefts. In more than two thirds of children with cleft lip and palate, the 
permanent upper incisors adjacent to the cleft defect were found to be missing or small.  
The research findings provided us with clues to clarify the biological mechanisms in people 
with different cleft malformations. Accurate findings are important in identifying at-risk 
individuals by precise matching of biological traits. Detailed information is needed for 
precision medicine, which offers us the best possible individualised approach to plan, prevent 






The global average for prevalence in births with orofacial clefts is 9.92 per 10,000. Variability 
in prevalence could be as much as a seven-fold difference in different ethnicities. Precise 
phenotyping and subphenotyping were essential in understanding the orofacial cleft phenome. 
Accurate characterizations to identify biomarkers in different cleft phenotypes would refine the 
diagnosis to advance personalised medicine in future prevention and treatments. 
Aims 
To establish the descriptive epidemiology of infants from different ancestries born with 
orofacial clefts, and to determine the primary and secondary dental anomalies and maturity in 
infants and children with different cleft-types. 
Materials 
Study I. Birth Defects Registry records of population live births of multiethnic infants in 
Singapore, with syndromic and non-syndromic orofacial clefts born in 2003 to 2012. 
Study II & III. Records of population live births of Northern European Danish infants with 
non-syndromic isolated cleft lip and isolated cleft palate born in 1976 to 1981. 
Study IV & V. Records of a cohort of consecutive children with non-syndromic unilateral cleft 
lip and palate treated in Singapore from 2010 to 2017. 
Methods:  
I. Retrospective population-based study of cleft-associated live births of different ethnicities to 
determine prevalence, trends, heterogeneity in cleft malformations, anomalies associated with 
cleft defects, and infant mortality rate.  
II and III. Retrospective population-based study of Northern European Danish infants with 
isolated unilateral cleft lip and isolated cleft palate to determine primary and secondary 
dentition anomalies and longitudinal dental maturity at 2 and 22 months of age. 
IV and V. Retrospective case-control cohort study of Singaporean children with unilateral cleft 
lip and palate to determine secondary dentition anomalies and longitudinal dental maturity at 





I. The overall population prevalence of cleft live births was 16.72 per 10,000 with a flat 
trendline over ten years. Ethnic-specific prevalence varied: Chinese, 17.17; Malay, 16.92; 
Indian, 10.74; and mixed ethnicities, 21.73. The infant mortality rate was 4.76%.  
II and III. There were no primary nor secondary dental anomalies in unoperated infants with 
isolated cleft palate. There were primary and secondary dental anomalies in infants with 
unilateral cleft lip. Dental maturity was delayed in infants of both cleft-types. 
IV and V. A high frequency of secondary dentition anomalies was detected in children with 
unilateral cleft lip and palate. Dental maturity was delayed and asymmetric with greater delay 
on the cleft side that normalised during adolescence. 
Conclusions:  
The prevalence of cleft live births was ethnic-specific and the mortality rate of infants with 
clefts was higher than the population norm. Infants with isolated cleft palate had no primary 
nor secondary dentition anomalies. Primary and secondary dental anomalies were present in 
infants and children with unilateral cleft lip, with and without cleft palate. Delayed dental 
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1.1 CLEFT LIP AND/OR PALATE 
1.1.1 Epidemiology 
Cleft lip and/or palate is one of the most common craniofacial birth defects. The global 
average in prevalence of births with cleft lip with and without cleft palate was 9.92 per 
10,000, reported by the Working group of the International Perinatal Database of Typical 
Oral Clefts [IPDTOC Working Group, 2011]. There were considerable variations in 
prevalence by geographical location with as much as a sevenfold difference between the 
highest and lowest reported rates (Fig.1). Comparative studies of groups with cleft lip and/or 
cleft palate demonstrated immigrants in new countries had similar prevalence of cleft births 
as the population in the old country [Ching et al., 1974; Leck et al., 1995; Croen et al., 1998; 
Kirby et al., 2000]. Ancestral genes are implicated but the aetiologies and biological 
pathways have yet to be elucidated.  
 
 
Figure 1. Global orofacial cleft prevalence per 10,000 by country (2000 to 2005).  
Data extracted from the International Perinatal Database of Typical Oral Clefts (IPDTOC Workgroup, 2011). 
 
Orofacial clefts phenotypes are heterogeneous and vary by cleft-types commonly classified 
as syndromic and non-syndromic orofacial clefts. There are grouped into three principal 
classes: cleft lip with or without cleft alveolus (cleft primary palate); cleft palate (cleft 
secondary palate); combination of cleft lip and cleft palate (cleft primary and secondary 
palate involvement) [Fogh-Andersen, 1942]. Non-syndromic cleft phenotypes are the most 
common that account for 85% of overall cleft-types. The frequency of syndromic orofacial 
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cleft phenotypes is less, 15% of overall cleft-types. Syndromic cleft phenotypes are 
associated with a recognisable spectrum of co-occurring disorders. There are more than 300 
identified syndromes associated with oral clefts [Mossey et al., 2012].  
1.1.2 Embryology 
Upper lip and palate development begin from the 4th intrauterine week of gestation. Paired 
facial swellings, the medial nasal and lateral nasal processes, develop on the frontonasal 
process of neural crest origin [Sperber et al., 2010]. By the 6th week, the upper lip and primary 
palate are formed from fusion of the medial nasal processes and paired maxillary processes 
[Jiang et al., 2006]. At about the same time, paired maxillary processes enlarge and form at the 
primitive mouth. Outgrowths of the maxillary processes begin to develop by the side of the 
tongue. By the end of the 8th week and beginning of the 9th week, palatal extensions of the 
paired maxillary processes rise above the descending tongue to meet and fuse in the midline 
with each other and the medial nasal processes. The fusion of the primary and secondary palates 
closes off the nasal from the oral cavity. Palatal development is completed by the 12th 
intrauterine week [Bush et al., 2012].  
 
Odontogenesis occurs at about the same time as facial development. The dental epithelium 
forms at 6 weeks intrauterine in the primitive mouth. The inner process or dental lamina 
invaginate into the mesenchyme to form teeth, whereas the outer process or vestibular lamina 
breaks down to form the vestibule, thus separating the tooth-bearing areas from the lips and 
cheeks [Hovorakova et al., 2018]. Two cell types contribute to tooth development: the oral 
epithelium that give rise to the ameloblasts and enamel of the crown; and the neural crest cells 
that give rise to the dental papilla and tooth follicle to form dentine, pulp and periodontal 
ligament to complete tooth formation. The development of the maxillary lateral incisor is 
notable in that the tooth is formed by two components of the dental epithelium, from fusion of 
the maxillary process and medial nasal process [Ooé, 1957]. If fusion of the medial nasal and 
the maxillary processes is disrupted, the consequence is a cleft dentoalveolus. The defect in 
fusion may involve one or both components of the dental epithelium that form the maxillary 
lateral incisor tooth. When this happens, a number of developmental tooth anomalies may 
occur, viz. tooth agenesis, microdontic tooth, supernumerary tooth, or talon cusp formation 
involving the maxillary lateral incisor. This explains why lateral incisor anomalies commonly 
co-exist with cleft malformations of the dentoalveolus in the primary palate. 
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1.1.3 Phenotypes  
Physical traits in individuals with cleft lip and/or palate are heterogeneous. The clinical 
presentations are non-standardised and highly variable such that individual descriptions are 
necessary for the clinical phenotype. The orofacial cleft phenotypes originate from defects of 
developmental processes in the first branchial arch and the broad classifications of cleft lip, 
cleft palate, and cleft lip with cleft palate were thought to be genetically distinct [Fogh-
Andersen, 1942; Whitaker et al., 1981; Harville et al., 2005; Grosen et al., 2010]. Global rate 
for the cleft phenotypes was 9.92 per 10,000 with sexual dimorphism associated with different 
cleft phenotypes. The cleft lip with or without cleft palate phenotype was more frequently 
found in males and the cleft palate only phenotype was more common in females. Laterality in 
individuals with cleft lip was not a random feature and presented more often on the left side: 
the global norm was 63.1% left-sided and 36.9% right-sided. Similarly, the cleft lip with cleft 
palate phenotype occurred more frequently on the left than right side, 58.9% and 41.1%, 
respectively. Bilateral cleft lip with involvement of both sides was less common, 10.3% 
[IPDTOC Working Group, 2011].  
 
1.1.4 Subphenotypes 
Subphenotypes were associated with a spectrum of traits that could be both obvious and hidden. 
The less visible traits reported were anomalies in the brain structure, lip prints, dentition and 
development, submucous clefts of the lip, dentoalveolus and palate, bifid uvula, and 
velopharyngeal insufficiency.  
 
1.1.4.1 Craniofacial subphenotype 
Many studies reported findings of the differences in the craniofacial structure of individuals 
with and without orofacial clefts. The syndromic craniofacial phenotype at one end of the 
spectrum was more obvious than the non-syndromic phenotype. Both intrinsic and extrinsic 
factors could bear upon the eventual outcomes of the craniofacial structure due to the long-
term developmental nature of orofacial formation. The cause and effect of the orofacial cleft 
facies were complex and unclear. Intrinsic dysplasia and extrinsic environmental influences 
had bi-directional effects that could modulate craniofacial growth concurrently or 
consequentially [Hermann et al., 2000; Kreiborg et al., 2006]. Functional adaptations to 
breathe, effects of inflammation and/or infections or the possibility of iatrogenesis from early 
surgery, these factors all play a role to a larger or lesser extent in affecting the outcomes of 




Growth potential in the mandible was found to be normal in unoperated infants with isolated 
cleft palate soon after birth. However, the infants had shorter mandibles that never caught up 
in length despite a normal growth rate. There was a trend in reduced mandibular size with 
increased severity of palatal defect in the infants [Eriksen et al., 2006]. The orofacial cleft 
phenotype in infants was distinctive despite the heterogeneity in cleft defects. In the Danish 
population-based cohort of infants with isolated cleft lip with and without cleft palate, and 
isolated cleft palate, all cleft phenotypes were characterised by bimaxillary retrognathism with 
increased transverse widths of the maxilla and nasal cavity. The size of the pharyngeal airway 
was reduced and related to the short and retrognathic mandible [Kreiborg et al., 2006]. 
1.1.4.2 Dental subphenotype 
Orofacial development is spatiotemporally regulated. There is coordinated timing of 
development in differentiation and/or fusion processes. The heterogeneity of cleft phenotypes 
could be demonstrated as anatomical defects linked to time-dependent disruptions in 
embryonic and/or foetal development. Based on this premise, the variability in severity of 
dental subphenotypes were ascribed to differentiation and/or fusion defects that corresponded 
to the timing of embryonic maldevelopment [Luijsterburg et al., 2014]. Due to the close 
association of cleft malformations and the frequency of dental anomalies, particularly tooth 
agenesis, developmental pathways regulated by common genes were speculated to be the 
cause. This led to the discovery of candidate genes for cleft malformations associated with 
tooth agenesis [Phan et al., 2016]. Their involvement implicated overlapping orofacial 
development and odontogenesis, and greater cleft severity was associated with increased dental 
anomalies. Individuals with bilateral clefts were frequently associated with higher frequencies 
in odontogenic defects than those with unilateral clefts [Dixon et al., 2011]. Dental maturation 
was delayed and the delay was greater on the cleft side than the non-cleft side in individuals 
with unilateral clefts [Eerens et al., 2001; Slayton et al., 2003; Aizenbud et al., 2005].  
Higher frequencies of odontogenic anomalies were found in the secondary dentition more so 
than in the primary dentition. Individuals with cleft defects involving the palate also presented 
with tooth agenesis at and remote from the cleft region. The prevalence of odontogenic 
anomalies increased along with the severity of the cleft defect. Postnatal development of the 
primary, mixed or permanent dentitions could be confounded by several environmental factors 
during a child’s growth and development. Heterogeneous characteristics of the dentition in 
individuals with clefts may represent abnormal development with multiple aetiologies that 
included infections or iatrogenic disruptions during early surgery [Kirkham, 1931; Jensen et 
al., 1983; Jugessur et al., 2009; Dentino et al., 2012; Phan et al., 2016; Korolenkova et a., 2018].  
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Biologically relevant groupings with careful distinctions would improve the power of 
genotype-phenotype precision in future research and diagnosis [Cox et al., 2018].  
1.1.5 Dental caries subphenotype 
Dental caries is reportedly higher in children with clefts than without clefts [Wells, 2014]. 
Previous reports have indicated a high prevalence of tooth anomalies in both primary and 
secondary dentitions that increased risks of dental caries individuals with orofacial clefts 
[Worth et al., 2017]. Increased susceptibility to tooth decay was attributed to a host of extrinsic 
and intrinsic factors related to the tooth subphenotype [Chu et al., 2016]. The interaction of 
several components was necessary to initiate dental decay, viz. tooth-surface, intraoral biofilm, 
substrate from the diet, salivary quality and quantity, and time (Fig. 2).  
 
 
Figure 2. Inter-relationship of the multifactorial components in dental caries. 
 
Caries prevention involved maintenance of a balance of the factors at play. An imbalance in 
any one of the components predisposed to dental decay [Selwitz et al., 2007; Aas et al., 2008]. 
Disrupted functions of the salivary glands and abnormal tooth development were found to be 
associated with a mutated gene, IRF6, a known candidate gene of syndromic and non-
syndromic cleft lip and palate phenotypes. Dental-specific IRF6-cKO, demonstrated in a 
murine model, substantially increased caries risk from defective tooth-patterning and 
amelogenesis in conjunction with salivary gland dysplasia that reduced salivary flow and 
protein production [Chu et al., 2016; Tamasas et al., 2016]. Other risk factors for dental caries 
in individuals with clefts were malaligned and/or hypoplastic teeth at the cleft site, circumoral 
tightness and stiffness of the scarred upper lip that reduced food shedding and access to the 
toothbrush, and orthodontic appliance interventions that modified biofilms on teeth. 
Individuals with clefts are at risk of dental caries due to a multitude of factors, and as such, it 
will be prudent to identify early strategies for caries prevention in this group. 
 
10 
1.1.6 Associated anomalies 
Associated anomalies are congenital defects characterized by functional, structural, 
morphological, or positional anomaly of a single or part of an organ co-occurring with the cleft 
malformation before birth. They can be recognized during prenatal assessments or at birth, 
although some structural or functional defects are detected a year after birth or even later 
[Impellizzeri et al., 2019].  
The prevalence of associated systemic anomalies in individuals with clefts vary from as low as 
1.5% to as high as 63% [Shprintzen et al., 1985]. The frequency of associated anomalies 
differed in different cleft phenotypes. It was reported to be lowest in individuals with cleft lip 
defects, between 7.6 to 41.4%, as opposed to a higher frequency in individuals with cleft lip 
and palate defects, ranging from 21.1 to 61.2%. Individuals with cleft palate have the highest 
frequency of associated systemic anomalies, 22.2 to 78.3% [Maarse et al., 2012].  
Defects of the heart, musculoskeletal system and nervous system were the most commonly 
detected associated anomalies in the cleft palate phenotype.  The order of defects in descending 
frequency found in the cleft lip with cleft palate phenotype was the heart, nervous system, and 
musculoskeletal system [Genisca et al., 2009]. One of the most commonly associated 
musculoskeletal anomalies involved defects in cervical vertebral fusion that affected more than 
50% of Swedish children with non-syndromic cleft lip and/or palate compared to children 
without clefts in a treatment centre [Karsten et al., 2019]. Due to advanced medical technology 
in routine obstetric screening, associated anomalies were diagnosed more often in individuals 
with orofacial clefts. Detection of anomalies in prenatal screening predicts presence of 
chromosomal abnormalities that require further tests and postnatal follow-up for timely and 
appropriate interdisciplinary management [Maarse et al., 2011]. 
1.1.7 Genetics, Epigenetics, and Environment 
1.1.7.1 Genetics 
In individuals with OFC syndromes, a recognisable cluster of physical and developmental 
anomalies is found. There are more than 350 syndromes associated with orofacial clefting 
documented in the Online Mendelian Inheritance in Man [OMIM®]. In individuals with 
syndromic clefts, 75% of them have a mutation at a single genetic locus transmitted by 
Mendelian inheritance. The most common syndromic cleft condition is the van der Woude 
syndrome that accounted for 2% of all cleft phenotypes [Kondo et al., 2002]. The syndromic 
orofacial cleft phenotypes were more likely to have cleft palate or cleft lip with cleft palate 
rather than cleft lip malformations [Leslie et al., 2013].  
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More individuals, 70%, are affected by non-syndromic than syndromic clefts. The aetiology 
is not straightforward as the disorder is not purely of genetic origin. With less than 50% 
concordance in monozygotic twins, variable expressivity and low penetrance, the cause of 
non-syndromic cleft phenotypes was postulated to be multiple genetic variants and 
environmental factors that occurred at different time-points during embryogenesis and foetal 
development. Much knowledge in the causal genes of non-syndromic cleft phenotypes was 
driven by gene discoveries in individuals with syndromic clefts [Rahimov et al., 2012; 
Luijsterburg et al., 2014; Beaty et al., 2016].  
 
With the use of complex genetic mapping, more than 30 candidate genes were identified in 
the non-syndromic cleft phenotypes [Genetics Home Reference]. Candidate genes, grouped 
by protein families, molecular functions, and biological functions, were different for the CP 
and CLP phenotypes. The CP phenotype was associated with the T-box, collagen-α chain, 
and TGF-β gene families whereas the CLP phenotype was associated with several, viz. 
heparin-binding FGF, patch-related, zinc-finger, neurotransmitter gated ion channel, tyrosine 
protein kinase, WNT-related, acyltransferase, intra-flagellar transport 140/170-related, 
transferase-related, and tropomyosin gene families. There was an overlap for both 
phenotypes in the homeobox domain [Funato et al., 2017; Leslie et al., 2017]. Genes 
associated with the tooth-agenesis cleft phenotype came from five major families: WNT, 
FGF, BMP, TGF and PAX [Phan et al., 2016] that encoded proteins for neural crest 
development in face, palate, dentoalveolus and teeth formation. In families of non-syndromic 
cleft individuals, de novo single gene mutations were identified. Pathogenic alleles were 
found in five genes, CTNND1, PLEKHA7, PLEKHA5, ESRP2, and CDH1 that were 
responsible for the deregulation of the epithelial adhesion pathway in the cause of non-
syndromic cleft lip with and without cleft palate phenotypes [Cox et al., 2018].  
 
1.1.7.2 Epigenetics  
In addition to genetics, epigenetics, which could be heritable, modified gene activity that 
affected the cleft phenotype at the cellular or organ level. It involved risk factors and complex 
mechanisms that could explain the inconsistencies in penetrance and expressivity of the OFC 
genotype-phenotype [Beames et al., 2020].  Distinguishable methylation profiles were found 
in the three cleft-types of cleft lip only, cleft palate only, and cleft lip and palate. A much greater 
methylation profile difference was detected between the cleft lip only group and the cleft palate 
only group. The cleft lip with cleft palate group was more similar to the cleft lip only group 
[Sharp et al., 2017]. While much progress has been made in identifying the genetic basis of 
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individuals with cleft lip and palate, not much is known about the mechanisms of epigenetics 
that affected the variability in phenotypic expressions. 
 
1.1.7.3 Environment 
Environmental or behavioural risk elements were implicated in the complex interaction of 
genetics and epigenetics in the causation of cleft lip and palate. A number of environmental 
factors was implicated as contributory to the multifactorial nature of orofacial cleft 
malformations: tobacco use, alcohol consumption, diet, pharmacological consumption, 
occupational/domestic exposures, infections, and maternal conditions [Garland et al., 2020; 
Martinelli et al., 2020]. Tobacco, in all its forms of consumption, exposed users to nicotine in 
cigarettes, e-cigarettes, cigars, hookah, and snus or snuff. Maternal exposures to first or second-
hand smoke were associated with significant 1.5-fold increase in pregnancy outcomes of 
infants born with non-syndromic orofacial clefts. Mothers consuming dissolvable tobacco in 
snus or snuff had similarly high odds of having babies born with orofacial clefts [Gunnerbeck 
et al., 2014]. A weaker association of pregnancy outcomes with orofacial clefts was found in 
the alcohol consumption group [Bille et al., 2007; Kummet et al., 2016].  
1.1.7.4 Maternal condition 
Maternal conditions that increased risks of orofacial clefts in the developing foetus were high 
maternal age, hypertension, preeclampsia, and diabetes mellitus [Gunnerbeck et al., 2014]. Pre-
gestational and gestational diabetes in pregnant mothers were significantly related to infants 
born with cleft palate and cleft lip with or without cleft palate. Pre-gestational diabetes was 
independent of increased body mass index (BMI) in the association of risks of infants born 
with defects, whereas gestational diabetes in combination with a BMI of 25 kg/m2 or greater 
was associated with increased risks of isolated or multiple birth defects [Correa et al., 2008]. 
Medication especially topiramate, used in maternal epilepsy, was associated with increased 
risks in pregnancy outcomes of infants with cleft lip with or without cleft palate [Alsaad et al., 
2015]. Maternal habitus and increased abdominal fat were associated with increased risks in 
foetal anomaly development. The risk of neural tube defects in foetal development increased 
by almost two-fold in pregnancies of women with greater BMI [Rasmussen et al., 2008].  
1.1.8 Multidisciplinary management 
 
The principal objectives in treatment of an individual with orofacial clefts were to achieve 
functional hearing, speech, eating, swallowing, and facial balance. A harmonious facial 
appearance was important for social acceptance and integration into the community. 
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Interdisciplinary management to repair and habilitate individuals with clefts required a high 
level of expertise and coordination of long-term healthcare services, and there could be lifelong 
implications depending on the severity of the cleft defect. 
Coordination of care was demanding and included the patients and families. Support services 
were required for feeding, and importantly, in coping skills to manage psychosocial challenges 
and expectations of growth and treatment outcomes. Depending on the severity of the cleft 
malformation, the coordinated and sequenced presurgical-surgical procedures, postsurgical 
evaluations, and long-term assessments, could be onerous with several surgeries and secondary 
revisions. Adequate support tailored to the needs of the patient and family was necessary to 
prevent treatment-fatigue in parents/caregiver and patients. An integrated team of trained 
multidisciplinary experts for long-term coordinated care of the patient was essential for good 
outcomes [American Cleft Palate-Craniofacial Association, 2018].  
1.1.9 Burden of care 
The number of treatment procedures that children with orofacial clefts could undergo varied 
as according to the severity of the cleft defect, the child’s age and needs, associated anomalies 
or other birth defects, and the expectations of the patients and families.  
1.1.9.1 Burden of treatment 
Depending on individual needs, the treatment protocol can span the period of time from soon 
after birth until the late teens or young adulthood. Surgery to repair a cleft lip is usually done 
in the first few months of life. If the infant does not meet the surgical “rule of 10s” in age (10 
weeks), weight (10 pounds), and haemoglobin (10 grams), primary surgery is delayed until 
the infant is fit for surgery. Surgery to repair a cleft palate is recommended within the first 
18 months of life or earlier for speech development [de Ladeira et al., 2012]. In coordination 
with primary surgical care, most children undergo a host of other treatments: early dental 
check-ups and care, speech therapy, audiology and sleep-disordered breathing assessments, 
otolaryngological interventions, alveolar bone grafting, orthodontic treatment, orthognathic 
surgery, and prosthodontics for malformed or missing teeth. Primary surgeries of the upper 
lip and soft palate to reposition and repair the disrupted lip and oropharyngeal muscles are 
necessary for normal swallowing and speech development. Secondary surgical revisions may 
be required to enhance nasolabial appearance although there was controversy over the 
effectiveness of secondary surgeries in improving primary surgical outcomes. More than half 
of the patients who underwent secondary revisions did not achieve improved outcomes in 
nasolabial appearance [Trotman et al., 2007; Long et al., 2011]. Subjectivity in appearance 
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assessments and socioeconomic circumstances played a role in the variable experiences that 
could increase the burden of secondary surgical care [Sitzman et al., 2015; 2020]. 
1.1.9.2 Burden of healthcare expenditure 
The goals in care of individuals with clefts were both function and cosmesis driven. The 
multitude of healthcare visits, assessments, multidisciplinary treatment sessions, primary and 
secondary surgeries, time, travel, and expenses, constituted an immense burden of care that 
could take a toll on the patient and family’s wellbeing in the long term. In countries with no 
socialised healthcare, a lifetime in private healthcare insurance expenditure for an individual 
with orofacial cleft was estimated to be $101,000 [Boulet et al., 2009]. Healthcare costs for 
children with clefts were eight times higher than that of unaffected children due to higher 
consumption of hospital services [Boulet et al., 2009; Wehby et al., 2012]. 
1.1.10 Patient-reported outcomes 
 
With growing emphasis on patient-centred care, patient-reported outcome measures (PROMS) 
are increasingly being used in determining healthcare outcomes. Measures focus on the 
concerns of patients to evaluate the effectiveness of different treatments. They are particularly 
useful in identifying alternative care. Patients are taken on board as integral members of the 
healthcare team to participate in formulating health policies, assessing treatment and outcomes, 
and establishing patient-safety guidelines [Rivera et al., 2019].   
 
The Cleft Hearing, Appearance and Speech Questionnaire (CHASQ), is an example of a 
PROMS questionnaire developed for self-reported outcome measures of individuals with cleft 
lip and palate. In comparing Swedish and British individuals with cleft lip and palate between 
9 to 20 years of age, both groups had similar CHASQ scores reflecting satisfaction in all three 
domains assessed [Stiernman et al., 2020]. In the cleft-specific patient-reported outcomes 
(CLEFT-Q) of individuals with cleft lip and palate from 12 countries, the need for further 
treatment was indicated by older females with visible facial scars [Klassen et al., 2018]. The 
findings from PROMS were at odds with professional opinions on secondary surgery [Sitzman 
et al., 2015, 2020]. It is evident that value-added care is only possible by patients and 
professionals coming together to understand what are the concerns important to patients that 





1.1.11 Quality of life 
Quality of life (QOL) is defined by the World Health Organisation (WHO) as “an individual’s 
perception of their position in life embedded in a cultural, social, and environmental context.” 
[WHO QOL Group, 1998]. The multi-dimensional aspects of the WHO QOL questionnaire 
involve subjective assessments of one’s own health, functional, and socioemotional wellbeing, 
satisfaction with the care given, and their sense of self [Skevington et al., 2004] that take into 
consideration the physical, psychological, social, family, and environmental aspects of QOL. 
Multiple impaired functions of individuals with orofacial clefts place them at risk of lower 
QOL. Coping challenges from having facial differences have significant impact on wellbeing, 
especially those with severe dentofacial discrepancies recommended for surgical interventions. 
Other factors affecting functional wellbeing were speech and dental development [Broder et 
al., 2014]. There were many QOL implications for individuals with clefts throughout their 
lives, chief among which was the significant expenditure in time and cost on healthcare use 
[Wehby et al., 2010]. The psychological health of children and adults with cleft lip and/or palate 









a) To establish the descriptive epidemiology of infants born with OFC of different ancestries 
in a multiethnic country. 
b) To determine the longitudinal prevalence and patterns of primary and secondary dentitions 
in infants with orofacial clefts. 
Specific: 
Study I. Establish the orofacial cleft live birth prevalence in the resident population groups 
with different ancestries, heterogeneity in cleft-types, and mortality rate of infants with 
orofacial clefts. 
Study II and III. Investigate dental anomalies and maturity of the primary and secondary 
dentitions in unoperated and operated infants with isolated unilateral cleft lip, and unoperated 
infants with isolated cleft palate. 
Study IV and V. Investigate dental anomalies and maturity of the secondary dentition in a 






3 MATERIALS AND METHODS 
 
3.1 STUDY GROUPS 
Study I. Registry data of resident population-based cleft live births (N=608) in a multiethnic 
country, Singapore. 
Study II and III. Registry data of population-based cleft live births of Northern European 
ancestry in Denmark: unoperated infants (2.3 months) with isolated unilateral cleft lip and 
isolated cleft palate (UCL, n=183; CP, n=83). Longitudinal follow-up of infants (22 months) 
with operated isolated unilateral cleft lip (UCL, n=111) and unoperated isolated cleft palate 
(CP, n=81). 
Study IV and V. National Dental Centre Singapore registry of consecutively treated cohort of 
children with unilateral cleft lip and palate (5 to 9 years, N=60; 9 to13 years, N=55).  
3.2 CONTROL GROUPS 
Study I. Registry data of resident population-based live births (N=363,633) in a multiethnic 
country, Singapore. 
Study II and III. The London Atlas of Human Dental Development and Eruption. 
Study IV and V. National Dental Centre Singapore’s registry of radiographs of children with 
no orofacial clefts (5 to13 years, N=115) with radiographs for dental treatment purposes.     
 
3.3 METHODS 
3.3.1 Study I 
The International Classification of Diseases 9th Edition (ICD-9) with Extension of the British 
Paediatric Association (BPA) Classification of Diseases (1979) Coding of Birth Defects [ICD-
9, 1979] was used for subjects registered from 2003 to 2011. Individuals registered from 2012 
onwards were coded using the International Classification of Diseases 10th Edition (ICD-10) 
Chapter XVII Royal College of Paediatric Child and Health Extension [ICD-10, 2004]. 
Extractions from the Registry’s database were done by using the following codes in ICD-9: 
749, and in ICD-10: Q35-Q37. Cleft laterality (side of the cleft), submucous cleft, bifid uvula 
and grading of the cleft defects were not classifiable by the codes and could not be recorded. 
The count of infants with clefts was by live pregnancy outcomes of Singaporean mothers 
grouped by ethnicity and registered by Immigration and Checkpoints Authority as resident 
 
18 
citizens or permanent residents living in Singapore in the period 2003 to 2012. Live births of 
foreigners in Singapore and Singaporeans who did not reside in the country were excluded. 
Stillbirths and abortions (spontaneous and elective) were also excluded.  
Resident population-based data were compiled from the Singapore National Birth Defects 
Registry. The database was compiled from multiple sources: the cytogenetics and 
histopathology laboratories, neonatal wards and maternity hospitals, medi-claims, birth defects, 
death certificates with reported congenital anomalies, stillbirths and abortuses (spontaneous 
and elective). The study population data sources comprised government organizations, public 
and private healthcare institutions. The data from 2003 to 2012 was compiled from multiple 
sources: cytogenetics and histopathology laboratories, neonatal wards and maternity hospitals, 
medi-claims, birth defects, death certificates with reported congenital anomalies, stillbirths and 
abortuses (spontaneous and elective). All data were anonymised by the Registry before study 
analysis.  
3.3.2 Study II and Study III 
 
Grading cleft defect severity: 
 
Figure 3. Classification of unilateral cleft lip severity. Adapted from Jensen et al., 1988. 
Grading of cleft lip severity (Fig. 3) was by the extent of involvement of the upper lip: Grade 
1 - up to one-third of the lip height from the lower vermilion border of the upper lip; Grade 2 - 
greater than one-third and up to two-thirds of the upper lip height; Grade 3 - greater than two-
thirds to subtotal of the upper lip height; Grade 4 - the total upper lip height. 
Grading of cleft palate severity (Fig. 4) was by the extent of involvement of the secondary 
palate: Grade 1 - soft palate only; Grade 2 - up to one-third of the palate from the posterior; 
Grade 3 - greater than one-third and up to subtotal of the palate from the posterior; Grade 4 - 




Figure 4. Grades of cleft palate severity. Adapted from Jensen et al., 1988. 
The primary dentition and longitudinal secondary dentition formation were evaluated by 
retrospective records and radiographs for anomalies in tooth-number and crown morphology. 
Dental maturation was assessed by tooth formation stages (Fig. 5 and Fig. 6).  
Staging dental maturity of infants at 2 and 22 months of age: 
 




Figure 6. Simulated radiographic stages of molar maturation. Adapted from Moorrees et al., 1963. 
 
Definition of tooth maturation stages [Moorrees et al., 1963]: Ci - initial cusp formation (not 
assessed as this stage is easily missed or mis-identified in the radiographs); Cco - coalescence 
of cusps; Coc - cusp outline complete; Cr½ - crown half completed with dentine formation; 
Cr¾ - crown three-quarters completed; Crc - crown completed with defined pulp roof; Ri - 
initial root formation with diverged edges. 
3.3.3 Study IV and Study V 
Staging dental maturity of children at 5 to 13 years of age:  
Secondary dentition formation and maturity were evaluated by retrospective records and 
radiographs for anomalies in tooth-number and crown morphology. Dental maturation was 
assessed by tooth formation stages (Fig. 7) as according to the definition of tooth maturation 
stages [Demirjian et al., 1973]: Stage A - cusp tips are calcified but are not fused yet; Stage B 
- calcified cusps are united so an outlined occlusal surface is well defined; Stage C - enamel 
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formation is complete at the occlusal surface. Dentinal deposition has commenced. The 
outlines of the pulp chamber are curved; Stage D - crown formation is complete to the 
cementoenamel junction. The pulp chamber in the uniradicular teeth is curved being concave 
toward the cervical region. In the molars, the pulp chamber has a trapezoid form. The pulp 
horns are beginning to differentiate. Root formation is seen; Stage E - the walls of the pulp 
chamber are straight. The pulp horns are more differentiated. The root length is less than the 
crown height. In molars, the radicular bifurcation is visible; Stage F - the walls of the pulp 
chamber now form an isosceles triangle. The apex ends in a funnel shape. The root length is 
equal to or greater than the crown height. In the molars, the bifurcation has developed 
sufficiently to give roots a distinct outline with funnel shaped endings; Stage G - the walls of 
the root canal are now parallel and its apical end is still partially open (distal root in molars); 
Stage H - the apical end of the root canal is completely closed (distal root in molars). The 
periodontal ligament has a uniform width around the root and the apex. 
 
 
Figure 7. Stages of secondary dentition maturation. Adapted from Demirjian et al., 1973. 
 
Study casts, dental panoramic, anterior maxillary occlusal, and periapical radiographs of the 
patients were examined for cleft-sidedness, congenitally missing permanent teeth, 
supernumerary teeth, microdontic, and macrodontic teeth in the anterior maxillary region, 
presence of malformed permanent cleft-sided lateral incisor and its morphology (peg-shaped, 
conical shaped, canine-formed), positions of the permanent lateral incisors relative to the cleft 
side and presence of rotated cleft-sided central incisors.  
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3.3.4 Statistical analysis 
 
Study I – Prevalence denominator was population live births per 10,000. Linear regression was 
used in trend tests and the significance level was set at 5%.  
 
Study II and III – Descriptive statistics of mean, standard deviation, median, minimum and 
maximum values, and frequencies and percentages for categorical variables. Cohen’s kappa 
coefficient was used to measure agreement in dental maturity assessments. Fisher’s exact test 
was used for associations between dental development stages by gender and grades of severity 
as well as to test for statistical differences in frequency of dentitional anomalies between male 
and female infants with UCL and between the UCL group and controls. The McNemar test 
was used in analysing agreement of dental anomalies in the two dentitions and dental maturity 
between the groups with UCL and CP. All tests performed were two-sided. The significance 
level was set at 5%.  
 
Study IV and V – Paired t-test was used to evaluate the comparison in the mean dental age 
delay between the groups with cleft and no cleft. Two-sample t-test and Kruskal-Wallis test 
were used to test for significant gender or ethnic differences. The dental age delay of 
complete UCLP subjects with and without hypodontia was compared using the Mann-
Whitney U test to determine if hypodontia affected the dental development. Spearman’s 
correlation coefficient evaluated the relationship between the severity of hypodontia and 
dental age delay. Poisson regression analysis with corrected multiplicative dispersion factor 
was used to compare the risk of asymmetric tooth pairs between the groups with and without 
clefts. The significance level was set at 5%.  
 
3.3.5 Error of the Method 
 
Study I – Ascertainment of every case-entry was matched against existing records in the 
system. The merging functions and contradiction modules checked, verified, and handled 
inconsistencies to resolve discrepancies and duplication. Field visits were conducted by the 
Registry coordinators at the medical records offices of restructured and private hospitals for 
data collection. Annual audits were done to standardise the definitions of data items and 
abstraction rules to ensure standards of consistency and accuracy in data collection. Inter-rater 
reliability audits of similar cases abstracted by the Registry coordinators were checked for 




Study II and III – Accuracy in establishing dental age for dental maturity was tested for 
reliability and precision by two orthodontists using the radiographs of 38 infants. Intra-assessor 
and inter-assessors’ determination of dental maturity ages were established by Cohen’s kappa 
coefficient for strengths of agreement, 0.9286 and 0.7994, respectively. Detection of dentition 
anomalies were repeated for all cases with perfect agreement. 
 
Study IV and V – The Demirjian’s Dental Development system was used to assess secondary 
dentition maturity. Intra-examiner reliability in assessing tooth formation by test-retest with 
60 teeth and analysed using the Cohen’s kappa coefficient, the strengths of agreement for 
each tooth ranged from 0.70 to 1.00. Detection of dentition anomalies were repeated for all 
cases with perfect agreement. 
 
3.3.6 Ethical Considerations 
The ethical implications in the use of registry data relevant to the studies are discussed here. 
The four principles in principlism [Gillon, 2003; Yan et al., 2004; Buchanan, 2008; Beauchamp 
et al., 2013] will be used in the discussion of the ethics involved in registry-based research.  
The four key principles are beneficence, non-maleficence, autonomy, and justice. These are 
the pillars in upholding the standards of practice by which all healthcare professionals are held 
accountable to. They form the framework and values for thought processes and decision-
making in adopting appropriate practices to do good, avoid harm, support and respect the 
independence of individual’s actions and rights, and fair play.  
The first principle of beneficence, to do good, was well considered in all the studies. The 
individuals were unaware of the situations and use of their medical, dental, and health 
information. It is possible for distress and discomfort to be experienced by individuals if they 
are informed of research findings of predictions in health risks and reduced life expectancy 
outcomes. The ethical stand is to exercise sensitivity in dissemination of information, 
particularly if it is by mass media and not a one-on-one. Pre-emptive public counselling should 
be made accessible to mitigate any negative impacts from discomfiture of individuals on 
receiving uncertain news. To uphold the principle of beneficence, patient-support programmes 
building on the knowledge from the research will prepare future safeguards of population 
health and psychological wellbeing of those affected. 
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The second principle of non-maleficence, to avoid harm, was addressed by ways to prevent 
breaches in confidentiality of personal data. Data extraction, anonymization and aggregation 
were done by a trusted party to preserve the privacy of individuals and confidentiality of 
personal medical information in all studies. Further safeguards were implemented by way of 
securing secondary data in a password-protected, non-networked computer within the 
institutions or encrypted data storage devices used by members of the research team.  
The third principle triggers a controversial point as there is lack of informed consent with no 
leeway for autonomy in the use of registry data for research. It can be argued as to what degree 
of sacrifice is acceptable in limiting an individual’s freedom of choice in giving up rights to 
privileged information to help others. The ethical standing on this issue is to weigh the benefits 
of the greater good versus autonomy. If a gain in knowledge of health-giving from research 
outweighs multiple chronic health issues, shortened life span, and onerous burden of care, then 
the ethic of civic virtue in pursuing the greater common good should be upheld.  
The fourth principle of justice is that of fair play. This principle ensures the interests of the 
vulnerable groups of infants and children are looked after. If studies of the infants and 
children’s records were done without merits or benefits, that would have been unjust scrutiny. 
The principle of justice is upheld in all the studies as the gain in knowledge has the potential 
for applications in present and future healthcare practices to improve the diagnoses, treatments 
and pregnancy outcomes.  
The Hippocratic Oath calls for obligations to provide health benefits with minimal harm. The 
four keys of principlism render a foundation by which healthcare professionals can fulfil the 
obligatory responsibilities to improve population health. The emphasis in research ethics using 




4.1 STUDY I 
Prevalence per 10,000 for live births of all clefts, isolated clefts with no associated 
malformations, cleft lip, cleft palate, cleft lip with cleft palate were 16.72, 8.77, 6.85, 3.16, and 
6.71, respectively. Prevalence stratified for gender and ethnicities were: male, 17.72; female, 
15.78; Chinese group, 17.17; Malay group, 16.92; Indian group, 10.74; and mixed ethnicity 
group, 21.73 (Fig. 8). Infants with isolated clefts, non-isolated clefts with other malformations, 
and syndromic clefts were 52.5%, 42.1% and 5.4%, respectively (Table 1). Upward trend in 
infants with clefts was not significant (p=0.317) (Fig. 9). The mortality rate in infants with 







4.2 STUDY II & III 
In infants with UCL, the frequencies of dental anomalies were high in both primary (38.3%) 
(Fig.10) and secondary (18.0%) dentitions. No primary or secondary dentition anomalies were 
observed in infants with CP. Longitudinal dental anomalies in the UCP group were dissimilar 
(p=0.003). Risk differences involved primary supernumerary teeth (p=0.0001) and talon cusp 
formation (p=0.0001), and secondary tooth-agenesis (p=0.001) of the maxillary lateral incisor 
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corresponding to side of the cleft lip when compared with the control (Table 2). Delayed 
primary and secondary dental maturation occurred in the UCL and CP groups, greater in infants 
with UCL (p<0.0001) (Table 3). Primary and secondary dental maturation featured sexual 
dimorphism with greater delay in males (UCL, p<0.0001; CP, 0.0001>p=0.001). The effect of 
cleft severity on dental maturation was significant in infants with UCL (p=0.0361) and CP 
(p=0.0175) in the primary but not secondary dentition. The findings underscore the importance 
of accurate deep phenotyping to decipher confounding variants in the genotype-phenotype 
driven precision medicine. 
 







   
 
  Table 3. Comparison of UCL and CP groups: chronological age and dental maturity. 
 
4.3 STUDY IV & V 
Of the 60 patients studied, 63.3% had hypodontia, 21.7% had supernumerary teeth, 69.6% had 
microdontia, and 12.5% had macrodontia in the secondary dentition. All of the cleft-sided 
permanent lateral incisors had associated anomalies, with a large proportion (43.1%) missing; 
and when present in 31 subjects, the majority (90.3%) was positioned distal to the cleft. Most 
of the cleft-sided permanent central incisors were rotated if present, and prevalent at 86.7% 
(Fig.11). Delayed dental maturation was found in the 5 to 9-year-old children with UCLP 
compared to controls by 0.55 years (standard deviation: 0.75) (p<0.001). There was no 
significant difference between the dental maturation of children with UCLP and controls in the 
9 to 13-year-old group (P=.744). The risk of developing asymmetric tooth-pairs in the group 
with UCLP at both age groups were significantly higher than the control group (p<0.001) 
(Table 4). 
 
Table 4. Comparison of cleft group and control: chronological age, dental age, 
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5.1 POPULATION SURVEILLANCE 
 
Public health surveillance is defined by the WHO as the ”continuous, systematic collection, 
analysis and interpretation of health-related data needed for the planning, implementation, and 
evaluation of public health practice” [WHO, 2012]. The purpose in population surveillance of 
infants born with orofacial cleft malformations is to monitor population reproductive health 
outcomes and healthcare resource planning to manage affected outcomes. An infant with a 
complete orofacial cleft malformation faced a slew of long-term challenges with chronic 
functional, physical, mental health and general health problems [Berg et al., 2016]. The health 
of every birth mattered and every birth of an infant with orofacial cleft malformation placed a 
burden on the family, community, and healthcare resources [Boulet et al., 2009; Galloway et 
al., 2017]. Most countries showed minor variations in up or downtrends in the prevalence of 
orofacial cleft births over the years. The mild fluctuations could be random due to diagnosis 
and documentation, coverage and reporting, and age of registration [Jensen et al., 1988; Grosen 
et al., 2010; Klintö et al., 2020].  
 
5.2 DETECTION AND DIAGNOSIS  
 
Advances in medical imaging made it possible for prenatal detection of foetuses with orofacial 
clefts. Extraoral and large clefts were easier to detect than intraoral clefts. As cleft 
malformations can be obvious or occult, different diagnostic tools are necessary.  
Ultrasonography in two or three-dimensional views, magnetic resonance imaging, computed 
tomography, and radiography, have been variously used to diagnose hidden malformations, 
e.g. subepithelial lip clefts, submucosal primary and secondary cleft palates, and the extent of 
the anomalies. Postnatal imaging that complement clinical diagnosis are routinely used in 
assessments for developmental or functional deficits in formulating treatment plans. Imaging 
protocols are routine in investigations for the follow-up of developmental and other associated 
anomalies in individuals with orofacial clefts [Abramson et al., 2015].  
 
In addition to morphological diagnosis, cytogenomics testing form a part of the comprehensive 
diagnosis in individuals with OFC. Chromosome microarray analysis and detailed molecular 
analysis are proposed in conjunction with precise phenotyping for the provision of personalised 
genetic service in predicting risks of recurrence for orofacial clefts [Cox et al., 2018; Lustosa-
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Mendes et al., 2020]. Genes were associated in the predictability of different cleft phenotypes 
that could be developed for future diagnostics [Huang et al., 2019].  
 
5.3 CRANIOFACIAL AND DENTAL DEVELOPMENT 
 
Orofacial and dental structures formation in the early stages of human development were 
tightly sequenced and coordinated under the control of genes in concert with the environment 
and epigenetics. Perturbations in embryogenesis led to maldevelopment in the embryo and 
foetus [Sperber et al., 2010]. Various biological pathways in the formation of the head and teeth 
were affected by genetic mutations that modified gene functions in four main pathways of 
development, viz. FGF, SHH, WNT, and TGF-β pathways [Oliver et al., 2020]. The clinical 
implications in disruption of these pathways were phenotypes with craniofacial anomalies, 
orofacial clefts and tooth anomalies.  
 
Orofacial structures, in particular the mandible, were found to be smaller in individuals with 
orofacial cleft malformations. The growth potential was normal although the vector of growth 
was different in the CP and the UCL phenotypes [Hermann et al., 2002; Kreiborg et al., 2006]. 
By the same token, prenatally developing teeth were smaller than that of infants with no clefts 
and dental maturation was delayed [Hermann et al., 2012; Hermann et al., 2017]. Delayed 
dental development and dental anomalies were common findings in inviduals with orofacial 
clefts. The amount of delay was variable, ranging from 0.2 to 0.9 years with a mean of 0.6 
years [van Dyck et al., 2019]. The maxillary lateral incisor tooth at the cleft site was the most 
vulnerable tooth for dental anomalies and delayed development. This was due to its position in 
the dental arch at the convergence of the maxillary and medial nasal processes during fusion 
[Hovorakova et al., 2018]. 
 
The evidence was conflicting with regards to the effects of cleft severity, cleft laterality and 
gender on dental maturation [van Dyck et al., 2019]. Findings were variously confounded by 
sampling, heterogeneity or homogeneity of the study samples, methodologies used in dental 
age ascertainment, and control groups for comparison. Due to slow development and different 
morphology of teeth in individuals with OFC, there were inherent technical errors in 
establishing dental age and the challenge was establishing the accuracy and reliability of the 






Depending on the severity of the individual’s OFC and the cleft team’s protocol, the intensity 
of team interactions, evaluations and interdisciplinary treatment procedures were variable. 
They encompassed multidisciplinary expertise from genetics, paediatrics, paediatric dentistry, 
orthodontics, audiology, speech, surgery, viz. craniofacial, plastic, oral and maxillofacial, and 
otolaryngologic, psychological and social services [American Cleft Palate-Craniofacial 
Association, 2018]. Treatment outcomes are hard to predict due to different malformations, 
variations in development, individual responses to various treatments, team protocol, and 
experience of the cleft team. Treatment impacts the wellbeing of all involved, the patient, the 
family unit, and the caregiver, particularly when treatment trajectories are long and spans the 
developmental duration of a child over 18 years [Sischo et al., 2017]. During the protracted 
period of treatment to deliver the objectives of care, it is important to assess patients, families, 
and caregivers to ensure the goal in helping the patients to achieve a good quality of life was 




The effectiveness of prevention programmes in births with orofacial clefts was questioned. The 
anticipated downtrend in prevalence of births with orofacial clefts was not evidenced after 
decades of folic acid use in preparation for pregnancy. To the contrary, some reports showed 
periconceptional intake of folic acid could actually increase the risk of cleft births, in particular, 
births of infants with the cleft lip and alveolus phenotype [Rozendaal et al., 2013]. Risk 
reduction was in the decreased number of infants with associated anomalies and not in infants 
born with orofacial clefts [Czeizel et al., 2013; Gildestad et al., 2015]. Considerable 
heterogeneity between studies confounded the findings and recommendations could not be 
substantiated in the use of folic acid for the prevention of births with orofacial clefts [Zhou et 
al., 2020]. The controversy continues and prevention remains uncertain. 
 
The orofacial cleft disorder is poorly understood without correct and comprehensive data. 
Consequent to that,  diagnosis and treatment planning are incomplete with improvised 
treatment along the way, and the prevention programme is ineffective. Without specialised 
manpower planning and training, resource allocation for healthcare and healthcare facilities 
becomes skewed and ineffectual. Reliable and correct data are challenging to attain but 
essential in the evaluation of the multiplex problems in individuals with orofacial clefts. The 
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way forward is personalised medicine over the traditional patient-management approach by 
generalised empirical evidence. Each individual does not mirror the mean as the mean is a 
lonely place to be [J.R.E. Mills, personal communication, 22 June 1987]. For appropriate 
initiatives and treatment to be implemented, it behooves all researchers in the orofacial field to 
gather representative data from precise phenotyping for accurate interpretations in the 
translation to precision medicine for upstream healthcare.  
 
5.6 STUDY I 
Population prevalence of live births with orofacial clefts 
Prevalence for cleft live births of the resident population in Singapore, without stillbirths and 
abortuses, was 16.7 per 10 000. It was 1.7 times higher than the global average of 9.92 per 
10,000. There trend was flat with no significant upward trend (p=0.317). In the decade from 
1993 to 2002, the prevalence was 18.7 per 10,000 with significant upward trend that included 
stillbirths and abortuses of residents, non-residents, and foreigners in Singapore [Tan et al., 
2008]. Prevalence in both decades were at the higher end of the global range from 2.89 to 23.85 
[IPDTOC Working Group, 2011].  
Ethnic-specific prevalence 
Singapore is an immigrant country with forebears from Malaysia, China and India. The group 
with Indian ancestry had the lowest prevalence, 10.74 per 10,000. Prevalence in the groups 
with Chinese and Malay ancestries was almost similar, 17.17, 16.92 per 10,000, respectively. 
The cleft prevalence of the ethnic groups resembled those in the old countries of their forebears. 
This corroborates with ethnic-specific prevalence may be linked to ancestral genes 
[Mukhopadhyay et al., 2020]. The group with the highest prevalence of 21.73 per 10,000 is the 
mixed ethnicity group. In comparison between the two decades, the prevalence of this group 
doubled over two decades, from 1.16 per 10,000 (from 1993 to 2002) to 21.73 per 10,000 (from 
2003 to 2012). The group with mixed ethnicities was very heterogeneous with Southeast Asian 
ancestries from Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, 
Thailand, and Vietnam. Population demographics in this group varied year by year due to 
changing immigration patterns, and late registration of older subjects with clefts could be the 





Gender and cleft-types 
Males had higher prevalence than females. The former was predisposed to cleft lip and palate 
or cleft lip only, whereas females tended to have cleft palate only. The role of gender in 
different cleft phenotypes was postulated to be due to the timing of embryological 
development, and slower palatal development could result in more cleft palate defects in 
females [Burdi et al., 1969]. Gender also represented a substantial estimated attributable 
fraction in non-modifiable factors for the population with OFC [Raut et al., 2019]. The 
multifactorial threshold (MFT) model predicted greater genetic liability within a population 
with higher overall cleft prevalence that predisposed to increased frequencies of severe cleft 
although the evidence was not conclusive [Mitchell et al., 2002].  
Associated malformations 
Syndromic clefts were more commonly associated with CP defects (55.6%) and half of infants 
with non-syndromic CP (50.2%) were associated with other malformations. The associated 
anomalies of infants with CP in the present study involved mostly the musculoskeletal system 
and heart anomalies. The findings concurred with other reports on the high frequency of 
associated anomalies with CP cases that should be routinely examined for additional 
malformations [Maarse, 2011]. The infant mortality rate of infants born with clefts was 4.8%. 
The majority of infants born with OFC who perished within the first year had associated 
anomalies. This was more than double the population infant mortality rate of 2.1%.  
Limitations 
The findings in this study are based on diagnostic data soon after birth. The high probability of 
under-reporting of cleft live births and associated malformations is likely and due to early 
registrations. Palatal defects can prove to be challenging to diagnose and associated 
comorbidities easily missed in small infants. Continual examination and diagnosis for data 
updates to the registry will improve accuracy in ascertainment of data. 
5.7 STUDY II & III 
Dental subphenotypes in infants with orofacial clefts 
Longitudinal samples from population-based cohorts of Northern European ancestry with two 
non-overlapping phenotypes of isolated cleft lip and isolated cleft palate were used to minimise 
the confounding effects of gender, ancestry, overlapping cleft-types, and treatment effects on 
the developing dentitions.  
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Dental anomalies in the primary and secondary dentitions 
The types of dental anomalies in the primary and secondary dentitions were different. 
Supernumerary primary teeth did not form secondary supernumerary teeth. The lack of 
concurrence in longitudinal dental anomalies of the primary and secondary dentitions 
associated with clefts suggested disturbed development that was time-dependent. Cleft lip was 
relatable to differentiation defects, and cleft palate was mostly due to fusion defects. In this 
study, the significant association of unilateral cleft lip and maxillary lateral incisors anomalies 
could well be a combination of late-stage differentiation and fusion defects of the lip and dental 
epithelium, respectively. The significant occurrence of missing permanent maxillary lateral 
incisors with unilateral cleft lip could be under the control of genes, epigenetics and/or the 
environment that could include treatment effects [Kirkham, 1931; Jugessur et al., 2009; 
Dentino et al., 2012; Phan et al., 2016; Korolenkova et a., 2018].  
There were no missing teeth in the primary dentition although there were missing permanent 
maxillary lateral incisors in infants with greater cleft lip severity of Grades 3 and 4, and in 
frequencies of 12.1% and 60.0%, respectively. The greater prevalence of missing teeth in the 
primary and secondary dentitions could also be attributed to different ancestral genes, 
epigenetics, and environmental effects or iatrogenesis.  
Dental Maturation 
Male infants, in both groups with UCL and CP, were significantly delayed in dental maturation 
compared to females. This could be related to normal sexual dimorphism of human biological 
development. Biological variation of dental maturation in children with no clefts was also 
similar in the control samples of the London Atlas [AlQahtani et al., 2010]. Females, in general, 
were found to be advanced in dental development compared to males [Stack, 1960] that could 
not be attributed to hormonal differences alone [Garn et al., 1959].  
Delayed dental maturation in the primary and secondary dentitions occurred in both groups 
with UCL and CP, which increased with cleft severity in infants with UCL and CP in the 
primary dentition but not in the secondary dentition. There was sexual dimorphism in delayed 
dental maturation that was more pronounced in males. The delay in dental maturation was 
greater in infants with UCL compared to infants with CP. 
In unoperated infants with clefts, cleft severity grades were inadequate to distinguish 
subphenotypic heterogeneity in infants with UCL and CP. Dental anomalies, including 
deviations in the number of primary teeth and malformations of primary teeth were traits that 
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defined the unoperated infants with UCL but not the unoperated infants with CP. Delayed 
dental maturation in the primary dentition characterised both the unoperated UCL and CP 
subphenotypes shortly after birth. The knowledge derived from this study of unoperated and 
operated infants with OFC provided information for guidance in patient/parent counselling, 
patient-management, planning of facilities, training of specialized manpower, and enlarging 
the knowledge base of the OFC phenome. The availability of comprehensive phenotypic data 
for integration with genomic data would facilitate precision medicine in developing strategies 
for future treatment and prevention.      
Limitations 
The main limitation in this study was the retrospective study design without matched 
population-based controls for comparison of dental anomalies and dental maturation. As it was 
not possible for a prospective control groups of infants without OFC, the best available 
historical controls were employed for comparisons in this study. Another limitation was in 
using a series of tooth stages to determine the overall dental maturation age. This was based on 
radiographic findings of unerupted teeth at one time-point, a “snap-shot” that was fitted into 
pre-determined age categories rather than establishing the continuous dental maturation age of 
individual teeth. Due to inherent delays in dental development, secondary tooth agenesis could 
have been overestimated whereas supernumerary teeth and talon cusp formation were possibly 
underestimated. Due to the inherent delay in tooth development, the frequency of secondary 
dental anomalies could be higher if the study samples were re-examined at an older age.  
5.8 STUDY IV & V 
 
Dental anomalies and maturation in the permanent dentition 
Children with unilateral cleft lip and palate were found to be associated with higher prevalence 
of dental anomalies such as hypodontia (63.3%), supernumerary teeth (21.7%), and 
abnormalities in tooth size, 69.6% had microdontia, and 12.5% had macrodontia. All of the 
cleft-sided permanent lateral incisors had associated anomalies, with a large proportion 
(43.1%) missing; and when present in 31 subjects, the majority (90.3%) was positioned distal 
to the cleft. Most of the cleft-sided permanent central incisors were rotated if present, and 
prevalent at 86.7%.  
Delayed dental maturation of the secondary dentition was found in the 5 to 9-year-old children 
with unilateral cleft lip and palate compared to controls by 0.55 years (standard deviation: 0.75) 
(p<0.001). There was no significant difference between the dental maturation of children with 
UCLP and controls in the 9 to 13-year-old age group (p=0.744). The group with unilateral cleft 
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lip and palate had higher risk of asymmetrically developing tooth pairs than the control group 
for both age groups (p<0.001). 
 
Limitations 
Tooth maturation stages are more obvious and more easily staged with shorter durations of 
tooth development in the younger age group than the older age group. There could be much 
more variation in dental maturation in the older age group as there were potentially more 
extrinsic postnatal environmental factors, infections and/or iatrogenesis that could have exerted 
their influence on the development of teeth with age. With tooth development slowing down, 
especially during the last stages of root development, assessment of tooth formation stages 
became challenging. There was uncertainty in accuracy of establishing root length in 
individuals with clefts as it was reportedly shorter than normal [Hunter, 1975]. The assessment 
of root length was all important in the Demirjian’s method of determination of dental 
maturation age [Demirjian et al., 1973]. In the older age group of children with clefts, usually 
two incompletely formed teeth were available for assessment, the second premolar and molar. 
With slow dental development, shorter root length in children with clefts, and uncertainty in 
timing of root closure, an overestimation was likely to be a recurrent systematic error in the 






6.1 STUDY I 
Prevalence of OFC was ethnic-specific and sexually dimorphic in Singapore with no rising 
trend. There was a twofold difference in prevalence in the ethnic groups with the highest and 
lowest frequencies. Prevalence was higher in males than females. Infants with cleft palate only 
were the most common compared to the cleft lip with cleft palate, and cleft lip only phenotypes. 
Mortality rate of infants with OFC was double that of the population’s infant mortality rate.  
6.2 STUDY II & III 
In unoperated Danish infants of Northern European descent with isolated cleft palate, there 
were no dental anomalies in both primary and secondary dentitions. In the group of infants with 
unilateral cleft of the lip without cleft palate, dental anomalies in the primary and secondary 
dentitions were dissimilar, the primary dentition group was unoperated and the secondary 
dentition group was the same group after surgery. Almost one third of infants with isolated 
unilateral cleft lip had supernumeraries of the primary maxillary lateral incisors associated with 
increased severity of the cleft lip. It suggested a cleft of the dental epithelium in a UCL 
subphenotype with forme fruste cleft dentoalveolus. Dental maturation delay was detected in 
both groups of infants with isolated unilateral cleft lip and isolated cleft palate. Increased cleft 
severity was associated with greater delayed maturation in the primary dentition but not in the 
secondary dentition.  
6.3 STUDY IV & V 
In operated Southeast Asian children with UCLP, about two thirds had dental anomalies of the 
secondary maxillary lateral incisors at the cleft site, commonly microdontia and missing teeth. 
Asymmetric dental maturation occurred in children with UCLP with delayed tooth 
development on the cleft-side of the maxilla. Dental maturational delay occurred in the 5 to 9-
year-old children with UCLP, which normalised to match that of children without clefts by the 





7 POINTS OF PERSPECTIVE 
The multiethnic population-based findings revealed high prevalence of live births with OFC in 
specific ethnic groups. High infant mortality was a crucial point for concern with a rising trend 
of infants with cleft palate and medical comorbidities, a common phenotype in the population. 
The survival of these infants with associated malformations in their first year is precarious and 
requires the use of highly specialized manpower, facilities and equipment. It comes at much 
cost to the parents and families, emotionally and financially, with a significant burden of care 
in long-term treatment and habilitation.  
Orofacial cleft phenotypes are variable in traits that are not immediately obvious as they are 
developmental in nature. As orofacial clefts and associated malformations occurred early in 
pregnancy, continued surveillance for data is important in decision-making for upstream 
management and prevention programmes of at-risk individuals. More information from 
research is needed to establish the variants and phenotypes with implications in reproductive 
health. Aggregated data and population-based information are not applicable to the individual 
and not all at-risk individuals are similar. As such, detailed evaluation of the clinical phenotype 
and molecular tests are necessary for personalised diagnosis and treatment indications.  
Several processes are necessary to enable the practice of precision medicine in this field:  
1. Early detection of a developing foetus with orofacial cleft and services in counselling and 
support for parents and their families. 
2. Personalised genetic service with molecular testing and detailed characterisations of the 
non-syndromic orofacial cleft phenotype, family and medical histories for recurrence risks. 
3. Facilitate informed decisions through education of those affected or are at-risk to provide 
support groups and research resources for information to help individuals, parents and 
families in understanding future implications: the downstream effects of the affected 
individual with orofacial clefts, general health and wellbeing, growth and development 
with and without treatment, schedule of coordinated multidisciplinary treatment, treatment 




My thanks are due to many people, without whom and their support, kindness, and love, I could 
not have made this journey. There are some groups of people and individuals that I 
acknowledge in this segment but I owe heaps of gratitude to more people than I can name here. 
To the wonderful team and staff at the Karolinska Institutet for showing me the ropes, helping 
me to find the way through mazes of corridors, and unlocking many locked doors - physically 
and metaphorically.  
To Agneta, my principal supervisor, I am overwhelmed by your kindness, your hospitality and 
soul-warming home-cooked meals. You gave so generously of yourself, your time and advice, 
in reading my manuscripts, and getting those interminable forms signed even while you were 
on a boat, waiting in airports or on a plane.  
To Margaret, my mentor, for always watching my back. I am inspired by your can-do spirit 
and wisdom that you bring to our têtê-à- têtês over meals in beautiful settings and in your home. 
Those moments have touched me deeply and will remain forever etched in my memory.  
To Heli who launched many lifeboats to save me from drowning in the sea of paperwork and 
getting them done at the eleventh hour, you deserve a medal.  
To Lena and Bo, my honorary adoptive Swedish “parents”, for looking after my wellbeing and 
Swedish education in the greater sense of learning. You found opportunities every time I was 
in Stockholm to show me what was important and beautiful in life - the people, culture, cuisine, 
architecture, parks and lakes in Sweden. Our shared moments on the many walks we took in 
Djurgården, visits to museums, churches, concerts, and conversations we had over the dining 
table or WhatsApp, were life-changing and much cherished.  
To Sarah, a fellow course-mate, for sharing and “following” me from Solna to Singapore, only 
to discover a member of the Burkhill clan has built a house in Singapore that is now a conserved 
building in the Singapore Botanic Gardens - may you find your home in Singapore too.  
To all the staff and students in KI (Huddinge and Solna) whom I came into contact with during 
courses or when I was lost or locked out by the ubiquitous locked doors - thank you for your 
assistance, guidance, support, camaraderie, opening the doors, and most of all, sharing at fika. 
Fikas were the moments of joy that fueled me and made the journey worthwhile. I can still taste 
the memories of steaming hot Swedish coffee with knäckebröd, kanelbullar and dammsugare, 
which are quite outstanding when taken in the company of the Swedes and Swedish jokes.  
To the amazing Danish team at the 3D Lab in the University of Copenhagen, you may be a 
compact team but you do punch above your weight in the work you do.   
To Sven, for everything! There aren’t enough pages to list all that you have done. You have 
been more than a supervisor, you have been a sage, mentor, and motivator. You were uplifting 
and inspirational in my academic pursuits. You shone the light to show the way at crossroads 
 
42 
to make the tough and wise decisions, and to stick to them. You were generous to a fault that 
fulfilled every sense of the word magnanimity - in the sharing of your intellect, academic 
experiences, and wisdom. You brought much to the learning table and filled it with your sharp 
mind, and from the world over, to engage in intellectual thought and discourse. My academic 
journey with you wasn’t just about teeth, it was broad-based research and education over lots 
of smørrebrød, explorations in art museums and castles, and discovering the Danish hygge and 
Ana’s amazing culinary treats. Thank you for an incredible journey and adventure in building 
the knowledge base. 
To Nuno and Tron, for your warm friendship. If tables can talk, the big table in the 3D Lab will 
have many a tale to tell about our ideas, conversations, jokes and ways to eat a flødeboller. 
Thank you for creating the highs and providing the sugar highs during the meetings.  
To all the SingHealth teams, Elaine and the Cleft and Craniofacial team, the Orthodontics team, 
the Oral Health ACP Office team, and the Singapore National Birth Defects Registry team, for 
your assistance and support, and for the hard work and commitment in all that you do behind 
the scenes. It has been inspiring to journey with all of you in this endeavour.   
To George, for your dedication and wisdom. It was inspiring to learn from you, to understand 
the needs and challenges in setting up a Registry and what works best in the interests of all 
involved. The dedication in how you teach to pass on the knowledge spoke volumes of your 
passion as an educator. The lunch hour huddles, spiced with wonderful curries, had all team 
members contributing that made for rich learning experiences. I am very fortunate to have been 
a beneficiary of all of that.   
To Aizhen, for your amazing memory and computing power of your brain. The team didn’t 
need a computer, we just needed you. You were a fount of knowledge on regulations and 
guidelines. With an amalgam of codes and interpretations in a plethora of timing, extensions 
and appendices, I am appreciative of your tenacity in sitting by me to work them out. 
To Yeng, for your patience in walking me through all the Registry forms and giving me the 
insight into the fieldwork that you and your teammates do to gather data. You and your team 
were inspiring in all that you do, frequently going the extra mile just to be sure the data 
collection from all sources were complete. 
To William, for your expertise and the ability to work the computer programmes. You stayed 
calm and constant despite the long hours it took to generate the data for us. You were a source 
of motivation and it was an honour to have worked with you. May you rest in peace. 
To Chong, Smee, Matt, Muffin, Boof, Popes and Kungz, my family, for sustaining me with 
unconditional love and support every step of the way in this adventure, for always standing by 
me, and for being my anchor and lifeforce. Team family, you are absolutely the very best! 
To the memory of my grandmother - Popor, my former roommate and confidant, for your love, 





Aas JA, Griffen AL, Dardis SR, Lee AM, Olsen I, Dewhirst FE, Leys EJ, Paster BJ. Bacteria 
of dental caries in primary and permanent teeth in children and young adults. J Clin Microbiol. 
2008 Apr;46(4):1407-1417.  
Abramson ZR, Peacock ZS, Cohen HL, Choudhri AF. Radiology of Cleft Lip and Palate: 
Imaging for the Prenatal Period and throughout Life. Radiographics. 2015 Nov-
Dec;35(7):2053-63. 
Aizenbud D, Camasuvi S, Peled M, Brin I. Congenitally missing teeth in the Israeli cleft 
population. Cleft Palate Craniofac J. 2005 May;42(3):314-317.  
Alansari R, Bedos C, Allison P. Living with cleft lip and palate: the treatment journey. Cleft 
Palate Craniofac J. 2014 Mar;51(2):222-229.  
AlQahtani SJ, Hector MP, Liversidge HM. Brief communication: The London atlas of human 
tooth development and eruption. Am J Phys Anthropol. 2010 Jul;142(3):481-490. 
Alsaad AM, Chaudhry SA, Koren G. First trimester exposure to topiramate and the risk of oral 
clefts in the offspring: A systematic review and meta-analysis. Reprod Toxicol. 2015 
Jun;53:45-50.  
American Cleft Palate-Craniofacial Association. Parameters for evaluation and treatment of 
patients with cleft lip/palate or other craniofacial anomalies. Cleft Palate Craniofac J. 2018 
Jan;55(1):137-156. 
Beaty TH, Marazita ML, Leslie EJ. Genetic factors influencing risk to orofacial clefts: today's 
challenges and tomorrow's opportunities. F1000Res. 2016 Nov 30;5:2800.  
Beames TG, Lipinski RJ. Gene-environment interactions: aligning birth defects research with 
complex etiology. Development. 2020 Jul 17;147(21):dev191064.  
Beauchamp T, Childress J. Principles of Biomedical Ethics, 7th Edition. New York: Oxford 
University Press, 2013. 
Berg E, Haaland ØA, Feragen KB, Filip C, Vindenes HA, Moster D, Lie RT, Sivertsen Å. 
Health status among adults born with an oral cleft in Norway. JAMA Pediatr. 2016 Nov 
1;170(11):1063-1070. 
Bessell A, Hooper L, Shaw WC, Reilly S, Reid J, Glenny AM. Feeding interventions for 
growth and development in infants with cleft lip, cleft palate or cleft lip and palate. Cochrane 
Database Syst Rev. 2011 Feb 16;2011(2):CD003315. 
 
44 
Bille C, Olsen J, Vach W, Knudsen VK, Olsen SF, Rasmussen K, Murray JC, Andersen AM, 
Christensen K. Oral clefts and life style factors--a case-cohort study based on prospective 
Danish data. Eur J Epidemiol. 2007;22(3):173-181.  
Boulet SL, Grosse SD, Honein MA, Correa-Villaseñor A. Children with orofacial clefts: 
health-care use and costs among a privately insured population. Public Health Rep. 2009 May-
Jun;124(3):447-453.  
British Paediatric Association Classification of Diseases. Codes designed for use in the 
classification of paediatric and perinatal disorders. London: British Paediatric Association 
(1979). 
Broder HL, Norman RG, Sischo L, Wilson-Genderson M. Evaluation of the similarities and 
differences in response patterns to the Pediatric Quality of Life Inventory and the Child Oral 
Health Impact Scores among youth with cleft. Qual Life Res. 2014 Feb;23(1):339-347. 
Buchanan DR. Autonomy, paternalism, and justice: ethical priorities in public health. Am J 
Public Health. 2008 Jan;98(1):15-21.  
Bush JO, Jiang R. Palatogenesis: morphogenetic and molecular mechanisms of secondary 
palate development. Development. 2012 Jan;139(2):231-243. 
Burdi AR, Silvey RG. Sexual differences in closure of the human palatal shelves. Cleft Palate 
J. 1969 Jan;6:1-7.  
Carroll K, Mossey PA. Anatomical variations in clefts of the lip with or without cleft palate. 
Plast Surg Int. 2012;2012:542078. Epub 2012 Nov 29. 
Ching GH, Chung CS. A genetic study of cleft lip and palate in Hawaii. I. Interracial crosses. 
Am J Hum Genet. 1974 Mar;26(2):162-176.  
Chu EY, Tamasas B, Fong H, Foster BL, LaCourse MR, Tran AB, Martin JF, Schutte BC, 
Somerman MJ, Cox TC. Full spectrum of postnatal tooth phenotypes in a novel IRF6 cleft lip 
model. J Dent Res. 2016 Oct;95(11):1265-1273.  
Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, Cleves MA, Riehle-
Colarusso TJ, Waller DK, Reece EA. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 
2008 Sep;199(3):237.e1-9.  
Cox LL, Cox TC, Moreno Uribe LM, Zhu Y, Richter CT, Nidey N, Standley JM, Deng M, 
Blue E, Chong JX, Yang Y, Carstens RP, Anand D, Lachke SA, Smith JD, Dorschner MO, 
Bedell B, Kirk E, Hing AV, Venselaar H, Valencia-Ramirez LC, Bamshad MJ, Glass IA, 
Cooper JA, Haan E, Nickerson DA, van Bokhoven H, Zhou H, Krahn KN, Buckley MF, 
Murray JC, Lidral AC, Roscioli T. Mutations in the Epithelial Cadherin-p120-Catenin 
Complex cause Mendelian non-syndromic cleft lip with or without cleft palate. Am J Hum 
Genet. 2018 Jun 7;102(6):1143-1157. 
 
 45 
Crockett DJ, Goudy SL. Cleft lip and palate. Facial Plast Surg Clin North Am. 2014 
Nov;22(4):573-586.  
Croen LA, Shaw GM, Wasserman CR, Tolarová MM. Racial and ethnic variations in the 
prevalence of orofacial clefts in California, 1983-1992. Am J Med Genet. 1998 Aug 
27;79(1):42-47.  
Czeizel AE. Is folic acid a risk factor for oral clefts? Eur J Epidemiol. 2013 Nov;28(11):841-
3. 
De Ladeira PR, Alonso N. Protocols in cleft lip and palate treatment: systematic review. Plast 
Surg Int. 2012;2012:562892.  
De Queiroz HAP, Herkrath FJ, Rebelo MA, Vettore MV. Measurement of health-related and 
oral health-related quality of life among individuals with non-syndromic orofacial clefts: a 
systematic review and meta-analysis. Cleft Palate Craniofac J. 2015 Mar;52(2):157-172. 
Demirjian A, Goldstein H, Tanner JM. A new system of dental age assessment. Hum Biol. 
1973 May;45(2):211-227.  
Dentino KM, Peck S, Garib DG. Is missing maxillary lateral incisor in complete cleft lip and 
palate a product of genetics or local environment? Angle Orthod. 2012 Nov;82(6):959-963.  
Dixon MJ, Marazita ML, Beaty TH, Murray JC. Cleft lip and palate: understanding genetic 
and environmental influences. Nat Rev Genet. 2011 Mar;12(3):167-178.  
Eerens K, Vlietinck R, Heidbüchel K, Van Olmen A, Derom C, Willems G, Carels C. 
Hypodontia and tooth formation in groups of children with cleft, siblings without cleft, and 
nonrelated controls. Cleft Palate Craniofac J. 2001 Jul;38(4):374-378.  
Eriksen J, Hermann NV, Darvann TA, Kreiborg S. Early postnatal development of the 
mandible in children with isolated cleft palate and children with non-syndromic Robin 
sequence. Cleft Palate Craniofac J. 2006 Mar;43(2):160-167.  
Fogh-Andersen P. Inheritance of harelip and cleft palate: contribution to the elucidation of  
the etiology of the congenital clefts of the face. Copenhagen: Nyt Nordisk Forlag; 1942. 
 
Funato N, Nakamura M. Identification of shared and unique gene families associated with oral 
clefts. Int J Oral Sci. 2017 Jun;9(2):104-109.  
Galloway J, Davies G, Mossey PA. International knowledge of direct costs of cleft lip 
and palate treatment. Arch Pediatr Surg. 2017 Jan;1(1):10-25. 
Garland MA, Reynolds K, Zhou CJ. Environmental mechanisms of orofacial clefts. Birth 
Defects Res. 2020 Nov;112(19):1660-1698. 
 
46 
Garn SM, Lewis AB, Polacheck DL. Variability of tooth formation. J Dent Res. 1959 Jan-
Feb;38(1):135-148. 
Genetics Home Reference. U.S. National Library of Medicine. https://ghr.nlm.nih.gov/ 
Genisca AE, Frías JL, Broussard CS, Honein MA, Lammer EJ, Moore CA, Shaw GM, Murray 
JC, Yang W, Rasmussen SA; National Birth Defects Prevention Study. Orofacial clefts in the 
National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A. 2009 
Jun;149A(6):1149-1158.  
Gillon R. Ethics needs principles - four can encompass the rest - and respect for autonomy 
should be "first among equals". J Med Ethics. 2003 Oct;29(5):307-312. 
Gildestad T, Bjørge T, Vollset SE, Klungsøyr K, Nilsen RM, Haaland ØA, Øyen N. Folic acid 
supplements and risk for oral clefts in the newborn: a population-based study. Br J Nutr. 2015 
Nov 14;114(9):1456-63.  
Grosen D, Chevrier C, Skytthe A, Bille C, Mølsted K, Sivertsen A, Murray JC, Christensen K. 
A cohort study of recurrence patterns among more than 54,000 relatives of oral cleft cases in 
Denmark: support for the multifactorial threshold model of inheritance. J Med Genet. 2010 
Mar;47(3):162-168.  
Gunnerbeck A, Edstedt Bonamy AK, Wikström AK, Granath F, Wickström R, Cnattingius S. 
Maternal snuff use and smoking and the risk of oral cleft malformations--a population-based 
cohort study. PLoS One. 2014 Jan 15;9(1):e84715. 
Harville EW, Wilcox AJ, Lie RT, Vindenes H, Abyholm F. Cleft lip and palate versus cleft lip 
only: are they distinct defects? Am J Epidemiol. 2005 Sep 1;162(5):448-453.  
Hermann NV, Jensen BL, Dahl E, Bolund S, Kreiborg S. Craniofacial comparisons in 22-
month-old lip-operated children with unilateral complete cleft lip and palate and unilateral 
incomplete cleft lip. Cleft Palate Craniofac J. 2000 May;37(3):303-317. 
Hermann NV, Zargham M, Darvann TA, Christensen IJ, Kreiborg S. Early postnatal 
development of the mandibular permanent first molar in infants with isolated cleft palate. Int J 
Paediatr Dent. 2012 Jul;22(4):280-5. 
Hermann NV, Darvann TA, Kreiborg S. Early post-natal development of the mandibular 
permanent first molar in infants with unilateral complete cleft lip and palate. Orthod Craniofac 
Res. 2017 Nov;20(4):196-201.  
Hovorakova M, Lesot H, Peterka M, Peterkova R. Early development of the human dentition 
revisited. J Anat. 2018 Aug;233(2):135-145. 
Huang L, Jia Z, Shi Y, Du Q, Shi J, Wang Z, Mou Y, Wang Q, Zhang B, Wang Q, Ma S, Lin 
H, Duan S, Yin B, Lin Y, Wang Y, Jiang D, Hao F, Zhang L, Wang H, Jiang S, Xu H, Yang 
 
 47 
C, Li C, Li J, Shi B, Yang Z. Genetic factors define CPO and CLO subtypes of 
nonsyndromicorofacial cleft. PLoS Genet. 2019 Oct 14;15(10):e1008357. 
Hunter WS. The effects of clefting on crown-root length, eruption, height and weight in twins 
discordant for cleft of lip and/or palate. Cleft Palate J. 1975 Apr;12:222-228.  
Impellizzeri A, Giannantoni I, Polimeni A, Barbato E, Galluccio G. Epidemiological 
characteristic of orofacial clefts and its associated congenital anomalies: retrospective study. 
BMC Oral Health. 2019 Dec;19(1):1-14. 
 
International Statistical Classification of Diseases and Related Health Problems: 9th revision. 
World Health Organization (1979). 
 
International Statistical Classification of Diseases and Related Health Problems: 10th revision. 
World Health Organization (2004). 
 
IPDTOC Working Group. Prevalence at birth of cleft lip with or without cleft palate: data from 
the International Perinatal Database of Typical Oral Clefts (IPDTOC). Cleft Palate Craniofac 
J. 2011 Jan;48(1):66-81. 
 
Jayaraman J, Wong HM, King NM, Roberts GJ. The French-Canadian data set of Demirjian 
for dental age estimation: a systematic review and meta-analysis. J Forensic Leg Med. 2013 
Jul;20(5):373-81. 
Jensen BL, Dahl E, Kreiborg S. Longitudinal study of body height, radius length and skeletal 
maturity in Danish boys with cleft lip and palate. Scand J Dent Res. 1983 Dec;91(6):473-481.  
Jensen BL, Kreiborg S, Dahl E, Fogh-Andersen P. Cleft lip and palate in Denmark, 1976-1981: 
epidemiology, variability, and early somatic development. Cleft Palate J. 1988 Jul;25(3):258-
269.  
Jiang R, Bush JO, Lidral AC. Development of the upper lip: morphogenetic and molecular 
mechanisms. Dev Dyn. 2006 May;235(5):1152-1166.  
Jugessur A, Farlie PG, Kilpatrick N. The genetics of isolated orofacial clefts: from genotypes 
to subphenotypes. Oral Dis. 2009 Oct;15(7):437-453.  
Karsten A, Sideri M, Spyropoulos M. Morphologic anomalies of upper cervical vertebrae in 
Swedish children born with non-syndromic cleft lip and/or palate compared to Swedish 
children without cleft. Cleft Palate Craniofac J. 2019 Jul;56(6):751-758.  
Kemaloğlu YK, Kobayashi T, Nakajima T. Analysis of the craniofacial skeleton in cleft 




Kirby R, Petrini J, Alter C. Collecting and interpreting birth defects surveillance data by 
hispanic ethnicity: a comparative study. The Hispanic ethnicity birth defects workgroup. 
Teratology. 2000 Jan-Feb;61(1-2):21-27. 
Kirkham HLD. Dentition in cleft palate cases. International Journal of Orthodontia, Oral 
Surgery and Radiography, 1931 Nov;17(11):1076-1083. 
Klassen AF, Riff KWW, Longmire NM, Albert A, Allen GC, Aydin MA, Baker SB, Cano SJ, 
Chan AJ, Courtemanche DJ, Dreise MM, Goldstein JA, Goodacre TEE, Harman KE, Munill 
M, Mahony AO, Aguilera MP, Peterson P, Pusic AL, Slator R, Stiernman M, Tsangaris E, 
Tholpady SS, Vargas F, Forrest CR. Psychometric findings and normative values for the 
CLEFT-Q based on 2434 children and young adult patients with cleft lip and/or palate from 12 
countries. CMAJ. 2018 Apr 16;190(15):E455-E462.  
Klintö K, Karsten A, Marcusson A, Paganini A, Rizell S, Cajander J, Brunnegård K, Hakelius 
M, Okhiria Å, Peterson P, Abdiu A, Havstam C, Mark H, Hagberg E, Björnström L, Wiedel 
AP, Becker M. Coverage, reporting degree and design of the Swedish quality registry for 
patients born with cleft lip and/or palate. BMC Health Serv Res. 2020 Jun 11;20(1):528. 
Kondo A, Matsuo T, Morota N, Kondo AS, Okai I, Fukuda H. Neural tube defects: Risk factors 
and preventive measures. Congenit Anom (Kyoto). 2017 Sep;57(5):150-156. 
Korolenkova MV, Starikova NV, Udalova NV. The role of external aetiological factors in 
dental anomalies in non-syndromic cleft lip and palate patients. Eur Arch Paediatr Dent. 2019 
Apr;20(2):105-111. 
Kreiborg S, Herman NV, Darvann TA. Characteristics of facial morphology and growth 
in infants with clefts. In: Berkowitz S. (eds) Cleft Lip and Palate. 2006. Springer, Berlin, 
Heidelberg.  
Kummet CM, Moreno LM, Wilcox AJ, Romitti PA, DeRoo LA, Munger RG, Lie RT, Wehby 
GL. Passive smoke exposure as a risk factor for oral clefts - a large international population-
based study. Am J Epidemiol. 2016 May 1;183(9):834-841.  
Leck I, Lancashire RJ. Birth prevalence of malformations in members of different ethnic 
groups and in the offspring of matings between them, in Birmingham, England. J Epidemiol 
Community Health. 1995 Apr;49(2):171-179.  
Leslie EJ, Marazita ML. Genetics of cleft lip and cleft palate. Am J Med Genet C Semin Med 
Genet. 2013 Nov;163C(4):246-258.  
Leslie EJ, Carlson JC, Shaffer JR, Butali A, Buxó CJ, Castilla EE, Christensen K, Deleyiannis 
FW, Leigh Field L, Hecht JT, Moreno L, Orioli IM, Padilla C, Vieira AR, Wehby GL, Feingold 
E, Weinberg SM, Murray JC, Beaty TH, Marazita ML. Genome-wide meta-analyses of 
nonsyndromic orofacial clefts identify novel associations between FOXE1 and all orofacial 
 
 49 
clefts, and TP63 and cleft lip with or without cleft palate. Hum Genet. 2017 Mar;136(3):275-
286.  
Li J, Rodriguez G, Han X, Janečková E, Kahng S, Song B, Chai Y. Regulatory mechanisms of 
soft palate development and malformations. J Dent Res. 2019 Aug;98(9):959-967.  
Lithovius RH, Ylikontiola LP, Harila V, Sándor GK. A descriptive epidemiology study of cleft 
lip and palate in Northern Finland. Acta Odontol Scand. 2014 Jul;72(5):372-375.  
Long RE Jr, Hathaway R, Daskalogiannakis J, Mercado A, Russell K, Cohen M, Semb G, 
Shaw W. The Americleft study: an inter-center study of treatment outcomes for patients with 
unilateral cleft lip and palate part 1. Principles and study design. Cleft Palate Craniofac J. 2011 
May;48(3):239-243. 
Luijsterburg AJ, Rozendaal AM, Vermeij-Keers C. Classifying common oral clefts: a new 
approach after descriptive registration. Cleft Palate Craniofac J. 2014 Jul;51(4):381-391.  
Lustosa-Mendes E, Santos APD, Vieira TP, Ribeiro EM, Rezende AA, Fett-Conte AC, 
Cavalcanti DP, Félix TM, Monlleó IL, Gil-da-Silva-Lopes VL. Identification of genomic 
imbalances in oral clefts. J Pediatr (Rio J). 2020 Jul 21:S0021-7557(20)30188-1. 
Maarse W, Pistorius LR, Van Eeten WK, Breugem CC, Kon M, Van den Boogaard MJ, Mink 
van Der Molen AB. Prenatal ultrasound screening for orofacial clefts. Ultrasound Obstet 
Gynecol. 2011 Oct;38(4):434-439.  
Maarse W, Rozendaal AM, Pajkrt E, Vermeij-Keers C, Mink van der Molen AB, van den 
Boogaard MJ. A systematic review of associated structural and chromosomal defects in oral 
clefts: when is prenatal genetic analysis indicated? J Med Genet. 2012 Aug;49(8):490-498.  
Martinelli M, Palmieri A, Carinci F, Scapoli L. Non-syndromic cleft palate: an overview on 
human genetic and environmental risk factors. Front Cell Dev Biol. 2020 Oct 20;8:592271.  
Mitchell LE, Beaty TH, Lidral AC, Munger RG, Murray JC, Saal HM, Wyszynski DF; 
International Consortium for Oral Clefts Genetics. Guidelines for the design and analysis of 
studies on non-syndromic cleft lip and cleft palate in humans: summary report from a 
Workshop of the International Consortium for Oral Clefts Genetics. Cleft Palate Craniofac J. 
2002 Jan;39(1):93-100.  
Moorrees CF, Fanning EA, Hunt EE Jr. Formation and resorption of three deciduous teeth in 
children. Am J Phys Anthropol. 1963 Jun;21(2):205-213.  
Moorrees CF, Fanning EA, Hunt EE Jr. Age variation of formation stages for ten permanent 
teeth. J Dent Res. 1963 Nov-Dec;42:1490-14502.  
Mossey PA, Modell B. Epidemiology of oral clefts 2012: an international perspective. Front 
Oral Biol. 2012;16:1-18.  
 
50 
Mukhopadhyay N, Bishop M, Mortillo M, Chopra P, Hetmanski JB, Taub MA, Moreno LM, 
Valencia-Ramirez LC, Restrepo C, Wehby GL, Hecht JT, Deleyiannis F, Butali A, Weinberg 
SM, Beaty TH, Murray JC, Leslie EJ, Feingold E, Marazita ML. Whole genome sequencing 
of orofacial cleft trios from the Gabriella Miller Kids First Pediatric Research Consortium 
identifies a new locus on chromosome 21. Hum Genet. 2020 Feb;139(2):215-226. 
OMIM®. http://www.ncbi.nlm.nih.gov/OMIM. 
Oliver JD, Turner EC, Halpern LR, Jia S, Schneider P, D'Souza RN. Molecular diagnostics and 
in utero therapeutics for orofacial clefts. J Dent Res. 2020 Oct;99(11):1221-1227. 
Ooé T. On the early development of human dental lamina. Okajimas Folia Anat Jpn. 1957 
Aug;30(2-3):198-210.  
Peltomäki T. The effect of mode of breathing on craniofacial growth revisited. Eur J Orthod. 
2007 Oct;29(5):426-429.  
Phan M, Conte F, Khandelwal KD, Ockeloen CW, Bartzela T, Kleefstra T, van Bokhoven H, 
Rubini M, Zhou H, Carels CE. Tooth agenesis and orofacial clefting: genetic brothers in arms? 
Hum Genet. 2016 Dec;135(12):1299-1327.  
Pinchi V, Vitale G, Pradella F, Farese L, Focardi M. Dental age estimation in children with 
chromosomal syndromes. J Forensic Odontostomatol. 2018 May 30;36(1):44-52. 
Rahimov F, Jugessur A, Murray JC. Genetics of non-syndromic orofacial clefts. Cleft Palate 
Craniofac J. 2012 Jan;49(1):73-91.  
Rajion ZA, Al-Khatib AR, Netherway DJ, Townsend GC, Anderson PJ, McLean NR, 
Samsudin AR. The nasopharynx in infants with cleft lip and palate. Int J Pediatr 
Otorhinolaryngol. 2012 Feb;76(2):227-234.  
Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube 
defects: a metaanalysis. Am J Obstet Gynecol. 2008 Jun;198(6):611-619.  
Raut JR, Simeone RM, Tinker SC, Canfield MA, Day RS, Agopian AJ. Proportion of orofacial 
clefts attributable to recognized risk factors. Cleft Palate Craniofac J. 2019 Feb;56(2):151-158. 
Rivera SC, Kyte DG, Aiyegbusi OL, Slade AL, McMullan C, Calvert MJ. The impact of 
patient-reported outcome (PRO) data from clinical trials: a systematic review and critical 
analysis. Health Qual Life Outcomes. 2019 Oct 16;17(1):156.  
Ruegg TA, Cooper ME, Leslie EJ, Ford MD, Wehby GL, Deleyiannis FW, Czeizel AE, Hecht 
JT, Marazita ML, Weinberg SM. Ear infection in isolated cleft lip: etiological implications. 
Cleft Palate Craniofac J. 2017 Mar;54(2):189-192. 
Selwitz RH, Ismail AI, Pitts NB. Dental caries. Lancet. 2007 Jan 6;369(9555):51-59.  
 
 51 
Sharp GC, Ho K, Davies A, Stergiakouli E, Humphries K, McArdle W, Sandy J, Davey Smith 
G, Lewis SJ, Relton CL. Distinct DNA methylation profiles in subtypes of orofacial cleft. Clin 
Epigenetics. 2017 Jun;9(1):63. eCollection 2017. 
Shkoukani MA, Chen M, Vong A. Cleft lip - a comprehensive review. Front Pediatr. 2013 
Dec 27;1:53. 
Shprintzen RJ, Siegel-Sadewitz VL, Amato J, Goldberg RB. Anomalies associated with cleft 
lip, cleft palate, or both. Am J Med Genet. 1985 Apr;20(4):585-595.  
Sischo L, Wilson-Genderson M, Broder HL. Quality-of-Life in children with orofacial clefts 
and caregiver well-being. J Dent Res. 2017 Dec;96(13):1474-1481.  
Sitzman TJ, Mara CA, Long RE Jr, Daskalogiannakis J, Russell KA, Mercado AM, Hathaway 
RR, Carle AC, Semb G, Shaw WC. The Americleft Project: burden of care from secondary 
surgery. Plast Reconstr Surg Glob Open. 2015 Aug 10;3(7):e442.  
Sitzman TJ, Carle AC, Lundberg JN, Heaton PC, Helmrath MA, Trotman CA, Britto MT. 
Marked variation exists among surgeons and hospitals in the use of secondary cleft lip surgery. 
Cleft Palate Craniofac J. 2020 Feb;57(2):198-207.  
Skevington SM, Lotfy M, O'Connell KA; WHOQOL Group. The World Health Organization's 
WHOQOL-BREF quality of life assessment: psychometric properties and results of the 
international field trial. A report from the WHOQOL group. Qual Life Res. 2004 
Mar;13(2):299-310.  
Slayton RL, Williams L, Murray JC, Wheeler JJ, Lidral AC, Nishimura CJ. Genetic association 
studies of cleft lip and/or palate with hypodontia outside the cleft region. Cleft Palate Craniofac 
J. 2003 May;40(3):274-279.  
Sperber GH, Sperber SM, Guttmann GD, Shelton CT. Craniofacial embryogenetics and 
development. People’s Medical Publishing House-USA. 2nd ed. 2010. 
Stack, M.V. Forensic estimation of age in infancy by gravimetric observations on the 
developing dentition. J. Forensic Sci. Soc.1960;1(1):49–59. 
Stiernman M, Klintö K, Persson M, Becker M. Scores of the Cleft Hearing, Appearance and 
Speech Questionnaire (CHASQ) in Swedish participants with cleft lip and/or cleft palate and a 
control population. Cleft Palate Craniofac J. 2020 Sep 4:1055665620952296.  
Stiernman M, Klintö K, Persson M, Becker M. Comparison of corresponding scores from the 
Cleft Hearing Appearance and Speech Questionnaire (CHASQ) and CLEFT-Q in Swedish 
patients with cleft lip and/or palate. Cleft Palate Craniofac J. 2020 Oct 13:1055665620964124. 
Tamasas B, Cox TC. Massively increased caries susceptibility in an Irf6 cleft lip/palate model. 
J Dent Res. 2017 Mar;96(3):315-322.  
 
52 
Tan KB, Tan KH, Yeo GS. Cleft deformities in Singapore: a population-based series 1993-
2002. Singapore Med J. 2008 Sep;49(9):710-714. 
Trotman CA, Phillips C, Essick GK, Faraway JJ, Barlow SM, Losken HW, van Aalst J, Rogers 
L. Functional outcomes of cleft lip surgery. Part I: Study design and surgeon ratings of lip 
disability and need for lip revision. Cleft Palate Craniofac J. 2007 Nov;44(6):598-606. 
Vanderas AP. Incidence of cleft lip, cleft palate, and cleft lip and palate among races: a review. 
Cleft Palate J. 1987 Jul;24(3):216-225.  
Van Dyck J, Cadenas de Llano-Pérula M, Willems G, Verdonck A. Dental development in 
cleft lip and palate patients: A systematic review. Forensic Sci Int. 2019 Jul;300:63-74.  
Wehby GL, Cassell CH. The impact of orofacial clefts on quality of life and healthcare use and 
costs. Oral Dis. 2010 Jan;16(1):3-10.  
Wehby GL, Goco N, Moretti-Ferreira D, Felix T, Richieri-Costa A, Padovani C, Queiros F, 
Guimaraes CV, Pereira R, Litavecz S, Hartwell T, Chakraborty H, Javois L, Murray JC. Oral 
cleft prevention program (OCPP). BMC Pediatr. 2012 Nov 26;12:184.  
Wells M. Review suggests that cleft lip and palate patients have more caries. Evid Based Dent. 
2014 Sep;15(3):79.  
Whitaker LA, Pashayan H, Reichman J. A proposed new classification of craniofacial 
anomalies. Cleft Palate J. 1981 Jul;18(3):161-176. 
WHO. The World Health Organisation Public Health Surveillance 2012. 
https://www.who.int/topics/public_health_surveillance/en/ 
WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality 
of life assessment. Psychol Med. 1998 May;28(3):551-558.  
Wilcox AJ, Lie RT, Solvoll K, Taylor J, McConnaughey DR, Abyholm F, Vindenes H, Vollset 
SE, Drevon CA. Folic acid supplements and risk of facial clefts: national population-based 
case-control study. BMJ. 2007 Mar 3;334(7591):464.  
Wirtz N, Sidman J, Block W. Clefting of the Alveolus: Emphasizing the distinction from cleft 
palate. Am J Perinatol. 2016 May;33(6):531-534. 
Wong Riff KWY, Tsangaris E, Goodacre TEE, Forrest CR, Lawson J, Pusic AL, Klassen AF. 
What Matters to Patients with Cleft Lip and/or Palate: An international qualitative study 
informing the development of the CLEFT-Q. Cleft Palate Craniofac J. 2018 Mar;55(3):442-
450.  
Worth V, Perry R, Ireland T, Wills AK, Sandy J, Ness A. Are people with an orofacial cleft at 




Yan EG, Munir KM. Regulatory and ethical principles in research involving children and 
individuals with developmental disabilities. Ethics Behav. 2004;14(1):31-49.  
Zhou Y, Sinnathamby V, Yu Y, Sikora L, Johnson CY, Mossey P, Little J. Folate intake, 
markers of folate status and oral clefts: An updated set of systematic reviews and meta-





10 PAPERS I-V 
 
 
